(Date:11/30/2009)...er 30, 2009 An international team of applied scie...Zrich have demonstrated compact, multibeam, and mu...rt of the light spectrum (infrared). By contrast, ...defined wavelength. The innovative multibeam laser...mote chemical sensing pollution monitoring, optica...
(Date:11/30/2009)...F MANOR, N.Y., Nov. 30 Good Public...or the publication of company-sponsored medical re...tish Medical Journal (BMJ). "The publication of GP...of providing support and guidance for industry spo...ts in the peer-reviewed medical literature," said ...
(Date:11/30/2009)...Nov. 30 BioMarin Pharmac... the Food and Drug Administration (FDA) has grante...(3,4-DAP), amifampridine phosphate, for the rare a...e (LEMS). 3,4-DAP has previously received orphan ...9, the Committee for Medicinal Products for Human ...
(Date:11/30/2009)...NDON, November 30 ApaTech, the rap...ope,s fastest growing,Biotech/Pharmaceutical/Medic...09 Technology Fast 500 for EMEA (Europe, Middle Ea...based on a companies, five-year revenue growth,fo... this period. This,achievement places ApaTech 9th ...
Breaking Biology Technology:Scientists demonstrate multibeam, multi-functional lasers 2ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 2ISMPP Announces Publication of Good Publication Practice for Communicating Company-Sponsored Medical Research: GPP2 Guidelines Published in the BMJ 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 2FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 3FDA Grants Orphan Drug Designation for 3,4-DAP for LEMS 4ApaTech is Europe's Fastest Growing Lifescience Company 2ApaTech is Europe's Fastest Growing Lifescience Company 3ApaTech is Europe's Fastest Growing Lifescience Company 4...7 The market for congestive heart,failure (CHF) d...7, and is,expected to reach $30 billion by 2017, a...Congestive Heart Failure: Major World Markets, Vol...driven by three factors: an,increased incidence of...n,search of targeted therapies which is creating o...
...ril 17 Spherix Incorporated,(Nasdaq: SPEX ) anno...perations. Mr. Brown will be monitoring and overse...rial regarding the use of Naturlose(R) as a,treatm...as allowed Spherix,to terminate its agreement with...r full control of the clinical trial and its pivot...
...7 SPO Medical Inc. (OTC:,SPOM), a leading develop...r,use in portable monitoring devices, today announ...Capital Ventures (ACV), a leading provider of,comp... cap community, as an,investor relations consultan...ve Officer of SPO Medical,commented, "As we contin...
Other Biology Technology:Genomics Likely to Replace Traditional Drug Therapies in Treating CHF 2Spherix Hires Key Employees 2SPO Medical Retains American Capital Ventures for Investor Relations Services 2SPO Medical Retains American Capital Ventures for Investor Relations Services 3Iscove's Modified Dulbecco's Medium (IMDM) from Sigma-Aldrich
Dulbecco's Modified Eagle's Medium - high glucose (DME) from Sigma-Aldrich
...r routine procedures. Hollandes contains formaldeh...l decalcify small bone specimens. Tissue that is f...ith most stains, and the cupric acetate in the sol...nophil and endocrine cell granules so that less ly...
...tograph/Mass Spectrometer, utilizing many of the h...igh throughput and excellent productivity, providi...io. Like the GCMS-QP2010 Plus, the GCMS-QP2010s fe...um separation, 20 temperature ramps, and both scan...
Biology Products: